Skip to main content

New Restrictions on Financial Conflicts of Interest in CME


As reported in The Carlat Psychiatry Blog, the American Medical Association recently approved a report that may have substantial impacts on industry funding of continuing medical education. This report, authored by the AMA's Council on Ethical and Judicial Affairs, recommends:

"When possible, CME should be provided without [industry] support or the participation of individuals who have financial interests in the educational subject matter. " (page 99 of report)


What good is such a qualified recommendation from a mere report? The difference is that this report comes from, and was officially approved by, the AMA. The Accreditation Council for Continuing Medical Education (ACCME), which certifies providers of CME, is tightly linked to the AMA, such that CME credits are labelled "AMA PRA Category 1 Credit". Thus, the ACCME will likely need to modify its Standards for Commercial Support to impose greater restrictions on how CME can be funded and on the use of speakers with financial conflicts of interest.

There is plenty of wiggle room in these recommendations. For example, the report concedes that in certain cases exceptions to restrictions on funding and speakers may be needed to permit access to high-quality events. Thus, it remains unclear how much this report and resultant changes in ACCME standards will actually change current practices.

Nonetheless, this is an important milestone in efforts to reduce conflicts of interest in CME.

Comments

thank you for sharing such nice information about Restriction for Financial conflicts.. i love to face this instead of going away...thank you for the post..
Anonymous said…
Emboldened to new heights of educational integrity with this clarion call will the AMA next be counseling the thousands of med and healthcare students (including minorities and financially disadvantaged) who currently receive scholarships from big pharma? A great opportunity to state their position on influence peddling went begging earlier this year when AMA received $250,000 from Pfizer for their Excellence in Medicine Awards.

Popular posts from this blog

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…

Opening the Black Box of LTACs: Podcast with Anil Makam

What happens in Long Term Acute Care Hospitals, or LTACs (pronounced L-tacs)?  I've never been in one.  I've sent patients to them - usually patients with long ICU stays, chronically critically ill, with a gastric feeding tube and a trach for ventilator support.  For those patients, the goals (usually as articulated by the family) are based on a hope for recovery of function and a return home.

And yet we learn some surprising things from Anil Makam, Assistant Professor of Medicine at UCSF.  In his JAGS study of about 14,000 patients admitted to LTACHs, the average patient spent two thirds of his or her remaining life in an institutional settings (including hospitals, LTACs and skilled nursing facilities).  One third died in an LTAC, never returning home.

So you would think with this population of older people with serious illness and a shorter prognosis than many cancers, we would have robust geriatrics and palliative care in LTACs?  Right? Wrong.

3% were seen by a geriatrici…